4569 — Kyorin Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥105bn
- ¥107bn
- ¥113bn
- 63
- 60
- 75
- 79
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 32,508 | 32,918 | 30,844 | 27,494 | 19,394 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 52,590 | 47,409 | 40,409 | 41,636 | 47,250 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 114,904 | 117,058 | 114,027 | 116,376 | 119,030 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 21,792 | 22,721 | 23,896 | 24,334 | 25,834 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 173,034 | 171,160 | 167,126 | 171,924 | 176,045 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 41,480 | 31,328 | 27,407 | 32,182 | 34,983 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 49,639 | 48,450 | 42,465 | 47,417 | 50,584 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 123,395 | 122,710 | 124,661 | 124,507 | 125,461 |
Total Liabilities & Shareholders' Equity | 173,034 | 171,160 | 167,126 | 171,924 | 176,045 |
Total Common Shares Outstanding |